Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200™.
This new technology is now available to help physicians objectively assess a patient’s pain in critical care situations, where
December 2016 – Israeli Society of Anesthesiology Annual Meeting
Join us at the annual meeting of the Israel Society of Anesthesiologists while we exhibit the novel NOL™ (Nociception Level) Index – a breakthrough in objective intraoperative pain monitoring (Dec 15-16, Tel-Aviv).
May 2016 – ASA’s Press Release About Dr. Ruth Edry and Prof. Daniel Sessler’s study
The American Society of Anesthesiologists (ASA) publicized Medasense’s latest study, led by Dr. Ruth Edry and co-authored by Prof. Daniel Sessler,
TV Interview with Medasense CEO on Channel 1 (Israel)
Check out the TV interview with CEO, Galit Zuckerman, on Channel 1 (Israel) explaining how Medasense’s proprietary technology can measure pain objectively (Hebrew).
Medasense Chosen as Start-Up to Watch
Medasense was independently chosen by the “MedTech Strategist” magazine, to be one of the “Start-Ups To Watch” in the most recent issue.The “MedTech Strategist” is a medical device magazine providing objective insight in to the most important topics and trends in the industry.